[[ODC internal ribosome entry site (IRES)]]

CATEGORIES: RNA, Non-coding RNA

In molecular biology, the ODC internal ribosome entry site (IRES) is an RNA element present in the 5' UTR of the mRNA encoding ornithine decarboxylase. It has been suggested that this IRES allows cap-independent translation of ornithine decarboxylase at the G2/M phase of the cell cycle,[tpl]cite journal|last=Pyronnet|first=S|coauthors=Pradayrol, L; Sonenberg, N|title=A cell cycle-dependent internal ribosome entry site.|journal=Molecular Cell|date=April 2000|volume=5|issue=4|pages=607–16|pmid=10882097[/tpl] however there is some doubt about this.[tpl]cite journal|last=Nishimura|first=K|coauthors=Sakuma, A; Yamashita, T; Hirokawa, G; Imataka, H; Kashiwagi, K; Igarashi, K|title=Minor contribution of an internal ribosome entry site in the 5'-UTR of ornithine decarboxylase mRNA on its translation.|journal=Biochemical and Biophysical Research Communications|date=Dec 7, 2007|volume=364|issue=1|pages=124–30|pmid=17927956|doi=10.1016/j.bbrc.2007.09.112[/tpl]  Translation from this IRES is activated by the zinc finger protein ZNF9 and by Poly(rC)-binding protein 2 (PCBP2).[tpl]cite journal|last=Gerbasi|first=VR|coauthors=Link, AJ|title=The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation.|journal=Molecular & cellular proteomics : MCP|date=June 2007|volume=6|issue=6|pages=1049–58|pmid=17327219|doi=10.1074/mcp.M600384-MCP200[/tpl][tpl]cite journal|last=Sammons|first=MA|coauthors=Antons, AK; Bendjennat, M; Udd, B; Krahe, R; Link, AJ|title=ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2.|journal=PLoS ONE|date=Feb 18, 2010|volume=5|issue=2|pages=e9301|pmid=20174632|doi=10.1371/journal.pone.0009301[/tpl]  It is also activated in Ras-transformed cells.[tpl]cite journal|last=Origanti|first=S|coauthors=Shantz, LM|title=Ras transformation of RIE-1 cells activates cap-independent translation of ornithine decarboxylase: regulation by the Raf/MEK/ERK and phosphatidylinositol 3-kinase pathways.|journal=Cancer Research|date=May 15, 2007|volume=67|issue=10|pages=4834–42|pmid=17510413|doi=10.1158/0008-5472.CAN-06-4627[/tpl]

==See also==

==References==

==Further reading==


